XML 53 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Renasant Corporation (Parent Company Only) Condensed Financial Information (Tables)
 12 Months Ended
Dec. 31, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
Balance Sheets
Balance Sheets
  
December 31,
 
2013
 
2012
Assets
 
 
 
Cash and cash equivalents(1)
$
9,723

 
$
3,883

Investments
7,315

 
6,568

Investment in bank subsidiary(1)
739,688

 
563,345

Accrued interest receivable on bank balances(1)
6

 
9

Stock options receivable(1)
1,967

 
102

Other assets
4,637

 
4,048

Total assets
$
763,336

 
$
577,955

Liabilities and shareholders’ equity
 
 
 
Junior subordinated debentures
$
94,187

 
$
75,609

Intercompany borrowed funds(1)
1,500

 
1,500

Accrued interest payable on intercompany borrowed funds(1)
25

 
21

Other liabilities
1,972

 
2,617

Shareholders’ equity
665,652

 
498,208

Total liabilities and shareholders’ equity
$
763,336

 
$
577,955

(1)
Eliminates in consolidation
Statements of Income
Statements of Income

  
Year Ended December 31,
 
2013
 
2012
 
2011
Income
 
 
 
 
 
Dividends from bank subsidiary(1)
$
19,303

 
$
18,117

 
$
17,071

Interest income from bank subsidiary(1)
10

 
16

 
30

Other dividends
492

 
114

 
81

Other income
39

 
22

 
202

Total income
19,844

 
18,269

 
17,384

Expenses
3,892

 
3,190

 
2,898

Income before income tax benefit and equity in undistributed net income of bank subsidiary
15,952

 
15,079

 
14,486

Income tax benefit
(1,352
)
 
(1,160
)
 
(989
)
Equity in undistributed net income of bank subsidiary(1)
16,183

 
10,398

 
10,157

Net income
$
33,487

 
$
26,637

 
$
25,632

(1)
Eliminates in consolidation
Statements of Cash Flows
Statements of Cash Flows
 
  
Year Ended December 31,
 
2013
 
2012
 
2011
Operating activities
 
 
 
 
 
Net income
$
33,487

 
$
26,637

 
$
25,632

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
Equity in undistributed net income of bank subsidiary
(16,183
)
 
(10,398
)
 
(10,157
)
Amortization/Depreciation/Accretion
21

 
(161
)
 
(350
)
Decrease (increase) in other assets
1,969

 
(418
)
 
183

(Decrease) increase in other liabilities
(122
)
 
2,139

 
590

Net cash provided by operating activities
19,172

 
17,799

 
15,898

Investing activities
 
 
 
 
 
Purchases of securities held to maturity and available for sale
(1,420
)
 
(3,515
)
 
—

Sales and maturities of securities held to maturity and available for sale
3,000

 
—

 
—

Investment in subsidiaries
—

 
—

 
(15,000
)
Net cash received in acquisition
3,917

 
—

 
—

Net cash used in investing activities
5,497

 
(3,515
)
 
(15,000
)
Financing activities
 
 
 
 
 
Cash paid for dividends
(19,303
)
 
(17,117
)
 
(17,071
)
Cash received on exercise of stock-based compensation
276

 
548

 
218

Excess tax(expense) benefits from exercise of stock options
198

 
(56
)
 
—

Proceeds from advances from bank subsidiary
—

 
1,500

 
—

Net cash (used in) provided by financing activities
(18,829
)
 
(15,125
)
 
(16,853
)
Increase (decrease) in cash and cash equivalents
5,840

 
(841
)
 
(15,955
)
Cash and cash equivalents at beginning of year
3,883

 
4,724

 
20,679

Cash and cash equivalents at end of year
$
9,723

 
$
3,883

 
$
4,724